Select Advanced Malignancies
📧 Sign up to get email alerts when something new happens for Select Advanced Malignancies.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-06-01Clinical Trial Update: A Phase 1/2, Open-label Study to Evaluate the Safety and Antitumor Activity of MEDI0680 (AMP-514) in Combination With Durvalumab Versus Nivolumab Monotherapy in Participants With Select Advanced Malignancies [Phase 1, Phase 2]
Phase 1/2 open-label study evaluating MEDI0680 (AMP-514) with durvalumab vs nivolumab monotherapy in select advanced malignancies, including…